New eye implant combo aims to tame glaucoma pressure
NCT ID NCT06066645
First seen Jan 28, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tests whether adding a tiny implant that releases medication (iDose TR) to another implant that helps fluid drain (iStent infinite) can lower eye pressure better than the drain implant alone. About 230 adults with open-angle glaucoma or high eye pressure will take part. The goal is to see if the combination is safe and more effective at controlling eye pressure over 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN ANGLE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Glaukos Clinical Study Site
RECRUITINGColorado Springs, Colorado, 80907, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.